AFT Pharmaceuticals Limited

NZSE:AFT Rapport sur les actions

Capitalisation boursière : NZ$335.6m

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

AFT Pharmaceuticals Croissance future

Future contrôle des critères 3/6

AFT Pharmaceuticals devrait augmenter ses bénéfices et son chiffre d'affaires de 18.1% et de 10.7% par an respectivement. Le BPA devrait croître de de 18% par an. Le rendement des capitaux propres devrait être 20% dans 3 ans.

Informations clés

18.1%

Taux de croissance des bénéfices

18.0%

Taux de croissance du BPA

Pharmaceuticals croissance des bénéfices54.5%
Taux de croissance des recettes10.7%
Rendement futur des capitaux propres20.0%
Couverture par les analystes

Low

Dernière mise à jour15 Sep 2024

Mises à jour récentes de la croissance future

AFT Pharmaceuticals Limited (NZSE:AFT) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

May 25
AFT Pharmaceuticals Limited (NZSE:AFT) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Recent updates

It's Unlikely That The CEO Of AFT Pharmaceuticals Limited (NZSE:AFT) Will See A Huge Pay Rise This Year

Jul 26
It's Unlikely That The CEO Of AFT Pharmaceuticals Limited (NZSE:AFT) Will See A Huge Pay Rise This Year

AFT Pharmaceuticals Limited (NZSE:AFT) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

May 25
AFT Pharmaceuticals Limited (NZSE:AFT) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Does AFT Pharmaceuticals (NZSE:AFT) Deserve A Spot On Your Watchlist?

May 22
Does AFT Pharmaceuticals (NZSE:AFT) Deserve A Spot On Your Watchlist?

Is Now The Time To Put AFT Pharmaceuticals (NZSE:AFT) On Your Watchlist?

Oct 17
Is Now The Time To Put AFT Pharmaceuticals (NZSE:AFT) On Your Watchlist?

Should You Be Adding AFT Pharmaceuticals (NZSE:AFT) To Your Watchlist Today?

May 23
Should You Be Adding AFT Pharmaceuticals (NZSE:AFT) To Your Watchlist Today?

Is AFT Pharmaceuticals Limited (NZSE:AFT) Trading At A 50% Discount?

Dec 01
Is AFT Pharmaceuticals Limited (NZSE:AFT) Trading At A 50% Discount?

We Discuss Whether AFT Pharmaceuticals Limited's (NZSE:AFT) CEO Is Due For A Pay Rise

Jul 30
We Discuss Whether AFT Pharmaceuticals Limited's (NZSE:AFT) CEO Is Due For A Pay Rise

With AFT Pharmaceuticals Limited (NZSE:AFT) It Looks Like You'll Get What You Pay For

Jun 02
With AFT Pharmaceuticals Limited (NZSE:AFT) It Looks Like You'll Get What You Pay For

Should You Be Impressed By AFT Pharmaceuticals Limited's (NZSE:AFT) ROE?

Mar 20
Should You Be Impressed By AFT Pharmaceuticals Limited's (NZSE:AFT) ROE?

A Quick Analysis On AFT Pharmaceuticals' (NZSE:AFT) CEO Compensation

Feb 13
A Quick Analysis On AFT Pharmaceuticals' (NZSE:AFT) CEO Compensation

Are AFT Pharmaceuticals's (NZSE:AFT) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Jan 23
Are AFT Pharmaceuticals's (NZSE:AFT) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Does AFT Pharmaceuticals (NZSE:AFT) Have A Healthy Balance Sheet?

Jan 02
Does AFT Pharmaceuticals (NZSE:AFT) Have A Healthy Balance Sheet?

Should AFT Pharmaceuticals (NZSE:AFT) Be Disappointed With Their 89% Profit?

Dec 12
Should AFT Pharmaceuticals (NZSE:AFT) Be Disappointed With Their 89% Profit?

AFT Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 21
AFT Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Prévisions de croissance des bénéfices et des revenus

NZSE:AFT - Estimations futures des analystes et données financières antérieures (NZD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
3/31/20272852925N/A3
3/31/20262592517N/A3
3/31/20252241712N/A3
3/31/2024195161929N/A
12/31/2023185131221N/A
9/30/202317511413N/A
6/30/202316611312N/A
3/31/202315711212N/A
12/31/202214914412N/A
9/30/202214117613N/A
6/30/202213518714N/A
3/31/202213020914N/A
12/31/202112515712N/A
9/30/202112011510N/A
6/30/2021116906N/A
3/31/20211138-51N/A
12/31/20201105-43N/A
9/30/20201073-26N/A
6/30/20201077310N/A
3/31/202010612815N/A
12/31/201910011712N/A
9/30/2019941159N/A
6/30/201989415N/A
3/31/201985-3-21N/A
12/31/201884-7-5-1N/A
9/30/201883-11-8-4N/A
6/30/201882-12-10-6N/A
3/31/201881-14-12-9N/A
12/31/201779-14N/A-13N/A
9/30/201776-14N/A-16N/A
6/30/201773-16N/A-18N/A
3/31/201769-18N/A-19N/A
12/31/201667-18N/A-20N/A
9/30/201664-18N/A-21N/A
6/30/201664-16N/A-17N/A
3/31/201664-13N/A-14N/A
12/31/201563-13N/A-12N/A
9/30/201562-13N/A-10N/A
6/30/201559-13N/A-11N/A
3/31/201556-13N/A-13N/A
3/31/201449-1N/A0N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de AFT ( 18.1% par an) est supérieure au taux d'épargne ( 2.8% ).

Bénéfices vs marché: Les bénéfices de AFT ( 18.1% par an) devraient croître plus rapidement que le marché NZ ( 18% par an).

Croissance élevée des bénéfices: Les bénéfices de AFT devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de AFT ( 10.7% par an) devrait croître plus rapidement que le marché NZ ( 4.2% par an).

Croissance élevée des revenus: Le chiffre d'affaires de AFT ( 10.7% par an) devrait croître plus lentement que 20% par an.


Prévisions de croissance du bénéfice par action


Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de AFT devrait être faible dans 3 ans ( 20 %).


Découvrir les entreprises en croissance